07/08/2026
Unusual behaviour in the cells of mothers and babies with preeclampsia may provide new therapeutic targets for the condition, finds a new UCL study led by Professor Sara Hillman (UCL EGA Institute for Women’s Health), Dr Yara Sánchez Corrales and Theodoros Xenakis (both UCL Great Ormond Street Institute of Child Health).
Senior author, Professor Sara Hillman said: “We studied individual cells from both the mother and the baby to see how their activity changes in healthy pregnancies compared with preeclampsia.
“This helped us to confirm some changes already suspected in the condition and also discover new ones.”
Learn more:
🔗 https://www.ucl.ac.uk/news/2026/jul/potential-new-therapeutic-targets-preeclampsia-discovered
Unusual behaviour in the cells of mothers and babies with preeclampsia may provide new therapeutic targets for the condition, finds a new UCL-led study.